Loading clinical trials...

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study | Clinical Trials | Clareo Health

RECRUITING

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

ARTISTRY - ARTICE® Therapy Registry Study

NCT07388628•Artcline GmbH

Summary

The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay

Exclusion Criteria

•\-

Locations (1)

Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin

Magdeburg, Germany

Key Dates

Start Date

September 25, 2025

Primary Completion Date

September 1, 2027

Completion Date

December 1, 2027

Last Updated

February 9, 2026

Enrollment

200

ESTIMATED participants

Conditions

SepsisSeptic ShockImmunoparalysis in Septic Shock

Contacts

Jens Altrichter, Dr. med.

CONTACT

+49 381 440 703 0 jens.altrichter@artcline.de

Judith Gross, M. Sc.

CONTACT

+49 1772216033 judith.gross@artcline.de

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm

NCT04850456

Critical IllnessSepsis, Severe

View study

RECRUITING

A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children

NCT04955210

Critical IllnessSevere Sepsis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

Inclusion Criteria

Exclusion Criteria

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm

A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock